Global Therapeutic Proteins and Oral Vaccines Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 105

Published Date: 01 Apr 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Therapeutic Proteins and Oral Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Therapeutic Proteins and Oral Vaccines size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Therapeutic Proteins and Oral Vaccines market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Therapeutic Proteins and Oral Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Therapeutic Proteins
    Oral Vaccines

Market segment by Application, can be divided into
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

Market segment by players, this report covers
    Abbott
    Amgen
    Biogen
    Eli Lilly and Company
    Roche
    Johnson and Johnson
    Merck
    Novo Nordisk
    Pfizer
    Sanofi
    Serum Institute of India
    Emergent Biosolutions
    TransAlgae
    MigVax
    Lumen Bioscience

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Therapeutic Proteins and Oral Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Therapeutic Proteins and Oral Vaccines, with revenue, gross margin and global market share of Therapeutic Proteins and Oral Vaccines from 2019 to 2021.
Chapter 3, the Therapeutic Proteins and Oral Vaccines competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Therapeutic Proteins and Oral Vaccines market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Therapeutic Proteins and Oral Vaccines research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Therapeutic Proteins and Oral Vaccines
    1.2 Classification of Therapeutic Proteins and Oral Vaccines by Type
        1.2.1 Overview: Global Therapeutic Proteins and Oral Vaccines Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Type in 2020
        1.2.3 Therapeutic Proteins
        1.2.4 Oral Vaccines
    1.3 Global Therapeutic Proteins and Oral Vaccines Market by Application
        1.3.1 Overview: Global Therapeutic Proteins and Oral Vaccines Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Global Therapeutic Proteins and Oral Vaccines Market Size & Forecast
    1.5 Global Therapeutic Proteins and Oral Vaccines Market Size and Forecast by Region
        1.5.1 Global Therapeutic Proteins and Oral Vaccines Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Therapeutic Proteins and Oral Vaccines Market Size by Region, (2016-2021)
        1.5.3 North America Therapeutic Proteins and Oral Vaccines Market Size and Prospect (2016-2026)
        1.5.4 Europe Therapeutic Proteins and Oral Vaccines Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size and Prospect (2016-2026)
        1.5.6 South America Therapeutic Proteins and Oral Vaccines Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Therapeutic Proteins and Oral Vaccines Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Therapeutic Proteins and Oral Vaccines Market Drivers
        1.6.2 Therapeutic Proteins and Oral Vaccines Market Restraints
        1.6.3 Therapeutic Proteins and Oral Vaccines Trends Analysis

2 Company Profiles
    2.1 Abbott
        2.1.1 Abbott Details
        2.1.2 Abbott Major Business
        2.1.3 Abbott Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.1.4 Abbott Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Abbott Recent Developments and Future Plans
    2.2 Amgen
        2.2.1 Amgen Details
        2.2.2 Amgen Major Business
        2.2.3 Amgen Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.2.4 Amgen Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Amgen Recent Developments and Future Plans
    2.3 Biogen
        2.3.1 Biogen Details
        2.3.2 Biogen Major Business
        2.3.3 Biogen Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.3.4 Biogen Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Biogen Recent Developments and Future Plans
    2.4 Eli Lilly and Company
        2.4.1 Eli Lilly and Company Details
        2.4.2 Eli Lilly and Company Major Business
        2.4.3 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.4.4 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Eli Lilly and Company Recent Developments and Future Plans
    2.5 Roche
        2.5.1 Roche Details
        2.5.2 Roche Major Business
        2.5.3 Roche Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.5.4 Roche Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Roche Recent Developments and Future Plans
    2.6 Johnson and Johnson
        2.6.1 Johnson and Johnson Details
        2.6.2 Johnson and Johnson Major Business
        2.6.3 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.6.4 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Johnson and Johnson Recent Developments and Future Plans
    2.7 Merck
        2.7.1 Merck Details
        2.7.2 Merck Major Business
        2.7.3 Merck Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.7.4 Merck Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Merck Recent Developments and Future Plans
    2.8 Novo Nordisk
        2.8.1 Novo Nordisk Details
        2.8.2 Novo Nordisk Major Business
        2.8.3 Novo Nordisk Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.8.4 Novo Nordisk Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Novo Nordisk Recent Developments and Future Plans
    2.9 Pfizer
        2.9.1 Pfizer Details
        2.9.2 Pfizer Major Business
        2.9.3 Pfizer Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.9.4 Pfizer Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Pfizer Recent Developments and Future Plans
    2.10 Sanofi
        2.10.1 Sanofi Details
        2.10.2 Sanofi Major Business
        2.10.3 Sanofi Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.10.4 Sanofi Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Sanofi Recent Developments and Future Plans
    2.11 Serum Institute of India
        2.11.1 Serum Institute of India Details
        2.11.2 Serum Institute of India Major Business
        2.11.3 Serum Institute of India Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.11.4 Serum Institute of India Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Serum Institute of India Recent Developments and Future Plans
    2.12 Emergent Biosolutions
        2.12.1 Emergent Biosolutions Details
        2.12.2 Emergent Biosolutions Major Business
        2.12.3 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.12.4 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Emergent Biosolutions Recent Developments and Future Plans
    2.13 TransAlgae
        2.13.1 TransAlgae Details
        2.13.2 TransAlgae Major Business
        2.13.3 TransAlgae Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.13.4 TransAlgae Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 TransAlgae Recent Developments and Future Plans
    2.14 MigVax
        2.14.1 MigVax Details
        2.14.2 MigVax Major Business
        2.14.3 MigVax Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.14.4 MigVax Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 MigVax Recent Developments and Future Plans
    2.15 Lumen Bioscience
        2.15.1 Lumen Bioscience Details
        2.15.2 Lumen Bioscience Major Business
        2.15.3 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product and Solutions
        2.15.4 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Revenue, Gross Margin and Market Share (2019-2021)
        2.15.5 Lumen Bioscience Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Therapeutic Proteins and Oral Vaccines Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Therapeutic Proteins and Oral Vaccines Players Market Share
        3.2.2 Top 10 Therapeutic Proteins and Oral Vaccines Players Market Share
        3.2.3 Market Competition Trend
    3.3 Therapeutic Proteins and Oral Vaccines Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Therapeutic Proteins and Oral Vaccines Revenue and Market Share by Type (2016-2021)
    4.2 Global Therapeutic Proteins and Oral Vaccines Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Application (2016-2021)
    5.2 Therapeutic Proteins and Oral Vaccines Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America Therapeutic Proteins and Oral Vaccines Revenue by Type (2016-2026)
    6.2 North America Therapeutic Proteins and Oral Vaccines Revenue by Application (2016-2026)
    6.3 North America Therapeutic Proteins and Oral Vaccines Market Size by Country
        6.3.1 North America Therapeutic Proteins and Oral Vaccines Revenue by Country (2016-2026)
        6.3.2 United States Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2016-2026)
        6.3.3 Canada Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2016-2026)
        6.3.4 Mexico Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe Therapeutic Proteins and Oral Vaccines Revenue by Type (2016-2026)
    7.2 Europe Therapeutic Proteins and Oral Vaccines Revenue by Application (2016-2026)
    7.3 Europe Therapeutic Proteins and Oral Vaccines Market Size by Country
        7.3.1 Europe Therapeutic Proteins and Oral Vaccines Revenue by Country (2016-2026)
        7.3.2 Germany Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2016-2026)
        7.3.3 France Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2016-2026)
        7.3.5 Russia Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2016-2026)
        7.3.6 Italy Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Therapeutic Proteins and Oral Vaccines Revenue by Type (2016-2026)
    8.2 Asia-Pacific Therapeutic Proteins and Oral Vaccines Revenue by Application (2016-2026)
    8.3 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Region
        8.3.1 Asia-Pacific Therapeutic Proteins and Oral Vaccines Revenue by Region (2016-2026)
        8.3.2 China Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2016-2026)
        8.3.3 Japan Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2016-2026)
        8.3.4 South Korea Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2016-2026)
        8.3.5 India Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2016-2026)
        8.3.7 Australia Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America Therapeutic Proteins and Oral Vaccines Revenue by Type (2016-2026)
    9.2 South America Therapeutic Proteins and Oral Vaccines Revenue by Application (2016-2026)
    9.3 South America Therapeutic Proteins and Oral Vaccines Market Size by Country
        9.3.1 South America Therapeutic Proteins and Oral Vaccines Revenue by Country (2016-2026)
        9.3.2 Brazil Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2016-2026)
        9.3.3 Argentina Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Therapeutic Proteins and Oral Vaccines Revenue by Type (2016-2026)
    10.2 Middle East & Africa Therapeutic Proteins and Oral Vaccines Revenue by Application (2016-2026)
    10.3 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Country
        10.3.1 Middle East & Africa Therapeutic Proteins and Oral Vaccines Revenue by Country (2016-2026)
        10.3.2 Turkey Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2016-2026)
        10.3.4 UAE Therapeutic Proteins and Oral Vaccines Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Therapeutic Proteins and Oral Vaccines Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Therapeutic Proteins and Oral Vaccines Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Therapeutic Proteins and Oral Vaccines Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Therapeutic Proteins and Oral Vaccines Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Region (2021-2026)
    Table 6. Abbott Corporate Information, Head Office, and Major Competitors
    Table 7. Abbott Major Business
    Table 8. Abbott Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 9. Abbott Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. Amgen Corporate Information, Head Office, and Major Competitors
    Table 11. Amgen Major Business
    Table 12. Amgen Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 13. Amgen Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Biogen Corporate Information, Head Office, and Major Competitors
    Table 15. Biogen Major Business
    Table 16. Biogen Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 17. Biogen Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors
    Table 19. Eli Lilly and Company Major Business
    Table 20. Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 21. Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Roche Corporate Information, Head Office, and Major Competitors
    Table 23. Roche Major Business
    Table 24. Roche Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 25. Roche Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Johnson and Johnson Corporate Information, Head Office, and Major Competitors
    Table 27. Johnson and Johnson Major Business
    Table 28. Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 29. Johnson and Johnson Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. Merck Corporate Information, Head Office, and Major Competitors
    Table 31. Merck Major Business
    Table 32. Merck Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 33. Merck Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. Novo Nordisk Corporate Information, Head Office, and Major Competitors
    Table 35. Novo Nordisk Major Business
    Table 36. Novo Nordisk Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 37. Novo Nordisk Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. Pfizer Corporate Information, Head Office, and Major Competitors
    Table 39. Pfizer Major Business
    Table 40. Pfizer Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 41. Pfizer Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. Sanofi Corporate Information, Head Office, and Major Competitors
    Table 43. Sanofi Major Business
    Table 44. Sanofi Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 45. Sanofi Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. Serum Institute of India Corporate Information, Head Office, and Major Competitors
    Table 47. Serum Institute of India Major Business
    Table 48. Serum Institute of India Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 49. Serum Institute of India Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 50. Emergent Biosolutions Corporate Information, Head Office, and Major Competitors
    Table 51. Emergent Biosolutions Major Business
    Table 52. Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 53. Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 54. TransAlgae Corporate Information, Head Office, and Major Competitors
    Table 55. TransAlgae Major Business
    Table 56. TransAlgae Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 57. TransAlgae Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 58. MigVax Corporate Information, Head Office, and Major Competitors
    Table 59. MigVax Major Business
    Table 60. MigVax Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 61. MigVax Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 62. Lumen Bioscience Corporate Information, Head Office, and Major Competitors
    Table 63. Lumen Bioscience Major Business
    Table 64. Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product and Solutions
    Table 65. Lumen Bioscience Therapeutic Proteins and Oral Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 66. Global Therapeutic Proteins and Oral Vaccines Revenue (USD Million) by Players (2019-2021)
    Table 67. Global Therapeutic Proteins and Oral Vaccines Revenue Share by Players (2019-2021)
    Table 68. Breakdown of Therapeutic Proteins and Oral Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 69. Therapeutic Proteins and Oral Vaccines Players Head Office, Products and Services Provided
    Table 70. Therapeutic Proteins and Oral Vaccines Mergers & Acquisitions in the Past Five Years
    Table 71. Therapeutic Proteins and Oral Vaccines New Entrants and Expansion Plans
    Table 72. Global Therapeutic Proteins and Oral Vaccines Revenue (USD Million) by Type (2016-2021)
    Table 73. Global Therapeutic Proteins and Oral Vaccines Revenue Share by Type (2016-2021)
    Table 74. Global Therapeutic Proteins and Oral Vaccines Revenue Forecast by Type (2021-2026)
    Table 75. Global Therapeutic Proteins and Oral Vaccines Revenue by Application (2016-2021)
    Table 76. Global Therapeutic Proteins and Oral Vaccines Revenue Forecast by Application (2021-2026)
    Table 77. North America Therapeutic Proteins and Oral Vaccines Revenue by Type (2016-2021) & (USD Million)
    Table 78. North America Therapeutic Proteins and Oral Vaccines Revenue by Type (2021-2026) & (USD Million)
    Table 79. North America Therapeutic Proteins and Oral Vaccines Revenue by Application (2016-2021) & (USD Million)
    Table 80. North America Therapeutic Proteins and Oral Vaccines Revenue by Application (2021-2026) & (USD Million)
    Table 81. North America Therapeutic Proteins and Oral Vaccines Revenue by Country (2016-2021) & (USD Million)
    Table 82. North America Therapeutic Proteins and Oral Vaccines Revenue by Country (2021-2026) & (USD Million)
    Table 83. Europe Therapeutic Proteins and Oral Vaccines Revenue by Type (2016-2021) & (USD Million)
    Table 84. Europe Therapeutic Proteins and Oral Vaccines Revenue by Type (2021-2026) & (USD Million)
    Table 85. Europe Therapeutic Proteins and Oral Vaccines Revenue by Application (2016-2021) & (USD Million)
    Table 86. Europe Therapeutic Proteins and Oral Vaccines Revenue by Application (2021-2026) & (USD Million)
    Table 87. Europe Therapeutic Proteins and Oral Vaccines Revenue by Country (2016-2021) & (USD Million)
    Table 88. Europe Therapeutic Proteins and Oral Vaccines Revenue by Country (2021-2026) & (USD Million)
    Table 89. Asia-Pacific Therapeutic Proteins and Oral Vaccines Revenue by Type (2016-2021) & (USD Million)
    Table 90. Asia-Pacific Therapeutic Proteins and Oral Vaccines Revenue by Type (2021-2026) & (USD Million)
    Table 91. Asia-Pacific Therapeutic Proteins and Oral Vaccines Revenue by Application (2016-2021) & (USD Million)
    Table 92. Asia-Pacific Therapeutic Proteins and Oral Vaccines Revenue by Application (2021-2026) & (USD Million)
    Table 93. Asia-Pacific Therapeutic Proteins and Oral Vaccines Revenue by Region (2016-2021) & (USD Million)
    Table 94. Asia-Pacific Therapeutic Proteins and Oral Vaccines Revenue by Region (2021-2026) & (USD Million)
    Table 95. South America Therapeutic Proteins and Oral Vaccines Revenue by Type (2016-2021) & (USD Million)
    Table 96. South America Therapeutic Proteins and Oral Vaccines Revenue by Type (2021-2026) & (USD Million)
    Table 97. South America Therapeutic Proteins and Oral Vaccines Revenue by Application (2016-2021) & (USD Million)
    Table 98. South America Therapeutic Proteins and Oral Vaccines Revenue by Application (2021-2026) & (USD Million)
    Table 99. South America Therapeutic Proteins and Oral Vaccines Revenue by Country (2016-2021) & (USD Million)
    Table 100. South America Therapeutic Proteins and Oral Vaccines Revenue by Country (2021-2026) & (USD Million)
    Table 101. Middle East & Africa Therapeutic Proteins and Oral Vaccines Revenue by Type (2016-2021) & (USD Million)
    Table 102. Middle East & Africa Therapeutic Proteins and Oral Vaccines Revenue by Type (2021-2026) & (USD Million)
    Table 103. Middle East & Africa Therapeutic Proteins and Oral Vaccines Revenue by Application (2016-2021) & (USD Million)
    Table 104. Middle East & Africa Therapeutic Proteins and Oral Vaccines Revenue by Application (2021-2026) & (USD Million)
    Table 105. Middle East & Africa Therapeutic Proteins and Oral Vaccines Revenue by Country (2016-2021) & (USD Million)
    Table 106. Middle East & Africa Therapeutic Proteins and Oral Vaccines Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Therapeutic Proteins and Oral Vaccines Picture
    Figure 2. Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Type in 2020
    Figure 3. Therapeutic Proteins
    Figure 4. Oral Vaccines
    Figure 5. Therapeutic Proteins and Oral Vaccines Revenue Market Share by Application in 2020
    Figure 6. Hospital Pharmacies Picture
    Figure 7. Retail Pharmacies Picture
    Figure 8. Online Pharmacies Picture
    Figure 9. Global Therapeutic Proteins and Oral Vaccines Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 10. Global Therapeutic Proteins and Oral Vaccines Revenue and Forecast (2016-2026) & (USD Million)
    Figure 11. Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Region (2016-2026)
    Figure 12. Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Region in 2020
    Figure 13. North America Therapeutic Proteins and Oral Vaccines Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 14. Europe Therapeutic Proteins and Oral Vaccines Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 15. Asia-Pacific Therapeutic Proteins and Oral Vaccines Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 16. South America Therapeutic Proteins and Oral Vaccines Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 17. Middle East and Africa Therapeutic Proteins and Oral Vaccines Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. Therapeutic Proteins and Oral Vaccines Market Drivers
    Figure 19. Therapeutic Proteins and Oral Vaccines Market Restraints
    Figure 20. Therapeutic Proteins and Oral Vaccines Market Trends
    Figure 21. Abbott Recent Developments and Future Plans
    Figure 22. Amgen Recent Developments and Future Plans
    Figure 23. Biogen Recent Developments and Future Plans
    Figure 24. Eli Lilly and Company Recent Developments and Future Plans
    Figure 25. Roche Recent Developments and Future Plans
    Figure 26. Johnson and Johnson Recent Developments and Future Plans
    Figure 27. Merck Recent Developments and Future Plans
    Figure 28. Novo Nordisk Recent Developments and Future Plans
    Figure 29. Pfizer Recent Developments and Future Plans
    Figure 30. Sanofi Recent Developments and Future Plans
    Figure 31. Serum Institute of India Recent Developments and Future Plans
    Figure 32. Emergent Biosolutions Recent Developments and Future Plans
    Figure 33. TransAlgae Recent Developments and Future Plans
    Figure 34. MigVax Recent Developments and Future Plans
    Figure 35. Lumen Bioscience Recent Developments and Future Plans
    Figure 36. Global Therapeutic Proteins and Oral Vaccines Revenue Share by Players in 2020
    Figure 37. Therapeutic Proteins and Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 38. Global Top 3 Players Therapeutic Proteins and Oral Vaccines Revenue Market Share in 2020
    Figure 39. Global Top 10 Players Therapeutic Proteins and Oral Vaccines Revenue Market Share in 2020
    Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 41. Global Therapeutic Proteins and Oral Vaccines Revenue Share by Type in 2020
    Figure 42. Global Therapeutic Proteins and Oral Vaccines Market Share Forecast by Type (2021-2026)
    Figure 43. Global Therapeutic Proteins and Oral Vaccines Revenue Share by Application in 2020
    Figure 44. Global Therapeutic Proteins and Oral Vaccines Market Share Forecast by Application (2021-2026)
    Figure 45. North America Therapeutic Proteins and Oral Vaccines Sales Market Share by Type (2016-2026)
    Figure 46. North America Therapeutic Proteins and Oral Vaccines Sales Market Share by Application (2016-2026)
    Figure 47. North America Therapeutic Proteins and Oral Vaccines Revenue Market Share by Country (2016-2026)
    Figure 48. United States Therapeutic Proteins and Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. Canada Therapeutic Proteins and Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. Mexico Therapeutic Proteins and Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Europe Therapeutic Proteins and Oral Vaccines Sales Market Share by Type (2016-2026)
    Figure 52. Europe Therapeutic Proteins and Oral Vaccines Sales Market Share by Application (2016-2026)
    Figure 53. Europe Therapeutic Proteins and Oral Vaccines Revenue Market Share by Country (2016-2026)
    Figure 54. Germany Therapeutic Proteins and Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. France Therapeutic Proteins and Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. United Kingdom Therapeutic Proteins and Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. Russia Therapeutic Proteins and Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. Italy Therapeutic Proteins and Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Asia-Pacific Therapeutic Proteins and Oral Vaccines Sales Market Share by Type (2016-2026)
    Figure 60. Asia-Pacific Therapeutic Proteins and Oral Vaccines Sales Market Share by Application (2016-2026)
    Figure 61. Asia-Pacific Therapeutic Proteins and Oral Vaccines Revenue Market Share by Region (2016-2026)
    Figure 62. China Therapeutic Proteins and Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. Japan Therapeutic Proteins and Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. South Korea Therapeutic Proteins and Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. India Therapeutic Proteins and Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. Southeast Asia Therapeutic Proteins and Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. Australia Therapeutic Proteins and Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. South America Therapeutic Proteins and Oral Vaccines Sales Market Share by Type (2016-2026)
    Figure 69. South America Therapeutic Proteins and Oral Vaccines Sales Market Share by Application (2016-2026)
    Figure 70. South America Therapeutic Proteins and Oral Vaccines Revenue Market Share by Country (2016-2026)
    Figure 71. Brazil Therapeutic Proteins and Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 72. Argentina Therapeutic Proteins and Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Middle East and Africa Therapeutic Proteins and Oral Vaccines Sales Market Share by Type (2016-2026)
    Figure 74. Middle East and Africa Therapeutic Proteins and Oral Vaccines Sales Market Share by Application (2016-2026)
    Figure 75. Middle East and Africa Therapeutic Proteins and Oral Vaccines Revenue Market Share by Country (2016-2026)
    Figure 76. Turkey Therapeutic Proteins and Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 77. Saudi Arabia Therapeutic Proteins and Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 78. UAE Therapeutic Proteins and Oral Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 79. Methodology
    Figure 80. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Abbott
Amgen
Biogen
Eli Lilly and Company
Roche
Johnson and Johnson
Merck
Novo Nordisk
Pfizer
Sanofi
Serum Institute of India
Emergent Biosolutions
TransAlgae
MigVax
Lumen Bioscience

Related Reports

Global Therapeutic Proteins and Oral Vaccines Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Therapeutic Proteins and Oral Vaccines Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 14 Jan 2022

date Pharma & Healthcare

The Therapeutic Proteins and Oral Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Product Tags

therapeutic proteins oral vaccines

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>